Hygeia Hospital
Athens 15123
3 studies enrolling now · 19 studies all time
What they study most
Atherosclerotic Cardiovascular Disease, Bradycardia, Breast Cancer, Colorectal Cancer (CRC), Coronary Heart Disease (CHD), Dilated Cardiomyopathy, Endometrial Cancer, Glioblastoma, Heart Failure, Heart Failure With Reduced Ejection Fraction (HFrEF), Metastatic Colorectal Cancer, Mitral Valve Regurgitation
Studies at this site
- Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation — Recruiting now
- Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity — Recruiting now
- Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C Mutation — Completed
- Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed
- Alleviant ALLAY-HFrEF Study — Enrolling by invitation
- Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study — Paused
- Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma — Running, not enrolling
- Male Breast Cancer: Understanding the Biology for Improved Patient Care — Running, not enrolling
- Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial — Running, not enrolling
- The CLASP Study Edwards PASCAL TrAnScatheter Mitral Valve RePair System Study — Completed
- Micra AV Transcatheter Pacing System Post-Approval Registry — Completed
- Personalized Therapy Study - Attain Stability Quad Post-Approval Study — Running, not enrolling
- CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG) — Running, not enrolling
- A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD) — Completed
- A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia — Completed
- Personalized Therapy Study - HFRS (TriageHF) Post Approval Study — Running, not enrolling
- Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS) — Running, not enrolling
- Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma — Completed
- BioVentrix Revivent TC™ System Clinical Study — Running, not enrolling